Outcome measures of phase III anticancer drug trials in China

Chin Med J (Engl). 2023 Apr 20;136(8):992-994. doi: 10.1097/CM9.0000000000002264. Epub 2023 Apr 7.
No abstract available

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • China
  • Humans
  • Neoplasms* / drug therapy
  • Outcome Assessment, Health Care

Substances

  • Antineoplastic Agents